Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Primary Research, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

7/30/2021
BreakingDry EyeGlaucomaIOLRetinaRevenue
Q2-2021 Ophthalmic Revenue Roundup: Novartis, Roche, Hoya, Lumibird
Q2-2021 Ophthalmic Revenue Roundup: Novartis, Roche, Hoya, Lumibird

Novartis reported July 21 that its Q2-2021 ophthalmology revenue totaled $1.1 billion, a 19 percent increase from $937 million in pandemic-impacted Q2-2020. Lucentis revenue outside the US in Q2-20...

7/30/2021
BreakingClinical TrialGene TherapyRetina
Adverum Drops ADVM-022 Gene Therapy Candidate in DME Over Safety Issues
Adverum Drops ADVM-022 Gene Therapy Candidate in DME Over Safety Issues

Adverum Biotechnologies reported July 22 thatit no longer plans to develop ADVM-022 for diabetic macular edema (DME) and will focus on low-dose use in wet age-related macular degeneration (AMD), ba...

7/30/2021
BreakingCataractDealsPharma
Harrow Acquires Rights to Candidate for Ocular Surface Anesthesia
Harrow Acquires Rights to Candidate for Ocular Surface Anesthesia

Harrow Health reported July 27 that it had agreed to acquire the US and Canadian marketing and supply rights to Sintetica’s AMP-100 (chloroprocaine 3% gel), a drug candidate intended to provide ocu...

7/30/2021
BreakingClinical TrialPharmaRetina
Enrollment Begins in Phase I Trial for Shanghai Henlius’ Ophthalmic Bevacizumab Biosimilar
Enrollment Begins in Phase I Trial for Shanghai Henlius’ Ophthalmic Bevacizumab Biosimilar

China’s Shanghai Henlius Biotech announced July 19 that the first patient had been dosed in its Phase I trial in China for HLX04-O in wet age-related macular degeneration (AMD). HLX04-O as an ophth...

7/30/2021
BreakingClinical TrialDeviceRetina
LumiThera Shares Positive Data from Pilot Study of Photobiomodulation’s Effect on ERG Outcomes
LumiThera Shares Positive Data from Pilot Study of Photobiomodulation’s Effect on ERG Outcomes

LumiThera, maker of the Valeda photobiomodulation (PBM) system, reported the final topline data on July 21 from its ELECTROLIGHT pilot study in intermediate dry age-related macular degeneration (AM...

7/30/2021
BreakingDealsPharmaRetina
Ocular Therapeutix, Mosaic Biosciences Collaborate on New Targets for Dry AMD
Ocular Therapeutix, Mosaic Biosciences Collaborate on New Targets for Dry AMD

Ocular Therapeutix has entered into a discovery collaboration with Mosaic Biosciences, of Boulder, Colorado, to identify new targets and therapeutic agents aimed at the treatment of dry age-related...

7/30/2021
BreakingDealsRetina
NGM, Merck Narrow Collaboration to Focus on Retinal, CVM Diseases
NGM, Merck Narrow Collaboration to Focus on Retinal, CVM Diseases

NGM Biopharmaceuticals announced July 1 that it had amended its agreement with Merck to extend the companies’ ongoing collaboration through March 2024 but with a narrower scope. The collaboration w...

7/30/2021
BreakingGene TherapyGlaucoma
Arctic Vision to Collaborate with Hong Kong Professor on Neuroprotection for Glaucoma
Arctic Vision to Collaborate with Hong Kong Professor on Neuroprotection for Glaucoma

Chinese company Arctic Vision announced July 4 a new research collaboration with Professor Christopher Leung, head of the Department of Ophthalmology of the University of Hong Kong, for the discove...

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

United States
US Surveys
May select more than one